These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21387654)

  • 1. [The cutting-edge of medicine; metabolic domino and CKD].
    Itoh H
    Nihon Naika Gakkai Zasshi; 2011 Jan; 100(1):191-8. PubMed ID: 21387654
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic kidney disease (CKD)--recent progress. Topics: VI. Chronic kidney disease (CKD) and associated disorders; 6. CKD associated with obesity and metabolic syndrome].
    Wakino S; Otoh H
    Nihon Naika Gakkai Zasshi; 2012 May; 101(5):1310-7. PubMed ID: 22693851
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of Metabolic Factors Associated with eGFR Decline Over 1 Year in a Japanese Population without CKD.
    Hayashi K; Takayama M; Abe T; Kanda T; Hirose H; Shimizu-Hirota R; Shiomi E; Iwao Y; Itoh H
    J Atheroscler Thromb; 2017 Aug; 24(8):863-875. PubMed ID: 28123142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Programs for continuing medical education: B session; 6. Metabolic syndrome and chronic kidney disease].
    Itoh H
    Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):710-6. PubMed ID: 24796141
    [No Abstract]   [Full Text] [Related]  

  • 5. Childhood Obesity and the Metabolic Syndrome.
    Nehus E; Mitsnefes M
    Pediatr Clin North Am; 2019 Feb; 66(1):31-43. PubMed ID: 30454749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: V. Extrahepatic manifestations: cerebral and cardiovascular diseases, chronic kidney disease].
    Imajo K; Yoneda M; Nakajima A
    Nihon Naika Gakkai Zasshi; 2016 Jan; 105(1):38-46. PubMed ID: 27266042
    [No Abstract]   [Full Text] [Related]  

  • 7. The metabolic syndrome and chronic kidney disease.
    Zhang X; Lerman LO
    Transl Res; 2017 May; 183():14-25. PubMed ID: 28025032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Chronic Kidney Disease in Turkish Adults With Obesity and Metabolic Syndrome: A Post Hoc Analysis from Chronic Renal Disease in Turkey Study.
    Arinsoy T; Deger SM; Ates K; Altun B; Ecder T; Camsari T; Serdengecti K; Suleymanlar G
    J Ren Nutr; 2016 Nov; 26(6):373-379. PubMed ID: 27641823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
    Ding C; Yang Z; Wang S; Sun F; Zhan S
    Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturia, sleep disturbance and the metabolic syndrome.
    Kupelian V
    J Urol; 2012 Dec; 188(6):2041-2. PubMed ID: 23000856
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of metabolic syndrome on resting energy expenditure in patients with chronic kidney disease.
    Rodrigues CQD; Santos JAP; Quinto BMR; Marrocos MSM; Teixeira AA; Rodrigues CJO; Batista MC
    Clin Nutr ESPEN; 2016 Oct; 15():107-113. PubMed ID: 28531773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between metabolic syndrome and chronic kidney disease in a Chinese urban population.
    Chen J; Kong X; Jia X; Li W; Wang Z; Cui M; Xu D
    Clin Chim Acta; 2017 Jul; 470():103-108. PubMed ID: 28501388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease and metabolic syndrome as risk factors for cardiovascular disease in a primary care program.
    Greffin S; André MB; Matos JPS; Kang HC; Jorge AJL; Rosa MLG; Lugon JR
    J Bras Nefrol; 2017; 39(3):246-252. PubMed ID: 28902230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obesity in metabolic syndrome, as well as kidney dysfunction].
    Sadulaeva IA; Vasyuk YA; Trofimenko OS; Yushchuk EN; Ivanova SV; Shupenina EY; Nesterova EA
    Ter Arkh; 2016; 88(10):93-98. PubMed ID: 28635857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study.
    Ma A; Liu F; Wang C; Liang K; Yan F; Hou X; Liu J; Chen L
    Int Urol Nephrol; 2018 Dec; 50(12):2239-2244. PubMed ID: 30182294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated glomerular filtration rate by two equations and their relationship with metabolic syndrome.
    Kawada T
    Clin Chim Acta; 2014 Nov; 437():220-1. PubMed ID: 24785583
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic syndrome and chronic kidney disease as risk factors of osteoporosis.
    Shin JH; Kim SH; Yu SH
    Clin Nephrol; 2014 Jan; 81(1):1-8. PubMed ID: 24356037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Authors reply: estimated glomerular filtration rate by two equations and their relationship with metabolic syndrome.
    Hong N; Oh J; Kang SM
    Clin Chim Acta; 2014 Nov; 437():222-3. PubMed ID: 24780580
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of metabolic syndrome and chronic kidney disease with atrial fibrillation: A nationwide population-based study in Korea.
    Choe WS; Choi EK; Han KD; Lee EJ; Lee SR; Cha MJ; Oh S
    Diabetes Res Clin Pract; 2019 Feb; 148():14-22. PubMed ID: 30578822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metabolic syndrome and of its individual components on renal function of patients with type 2 diabetes mellitus.
    Moehlecke M; Leitão CB; Kramer CK; Rodrigues TC; Nickel C; Silveiro SP; Gross JL; Canani LH
    Braz J Med Biol Res; 2010 Jul; 43(7):687-93. PubMed ID: 20549138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.